BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8094236)

  • 1. Effects of quinpirole on the behaviour shown by mice in the light-dark box and during social interactions.
    Gao B; Cutler MG
    Neuropharmacology; 1993 Jan; 32(1):93-100. PubMed ID: 8094236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute administration of the 5-HT3 receptor antagonist, BRL 46470A, on the behaviour of mice in a two compartment light-dark box and during social interactions in their home cage and an unfamiliar neutral cage.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Aug; 31(8):743-8. PubMed ID: 1356251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acute and subchronic administration of propranolol on the social behaviour of mice; an ethopharmacological study.
    Gao B; Cutler MG
    Neuropharmacology; 1992 Aug; 31(8):749-56. PubMed ID: 1528404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. A behavioural and biochemical study.
    Jackson DM; Ross SB; Larsson LG
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):355-65. PubMed ID: 2573842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and subchronic administration of ritanserin on the social behaviour of mice.
    Gao B; Cutler MG
    Neuropharmacology; 1993 Mar; 32(3):265-72. PubMed ID: 8474622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the benzodiazepine receptor inverse agonist, DMCM, on the behaviour of mice: an ethopharmacological study.
    Cutler MG; Aitken CC
    Neuropharmacology; 1991 Dec; 30(12A):1255-61. PubMed ID: 1664917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological responsiveness to the dopamine agonist quinpirole in normal weanlings and in weanling offspring exposed gestationally to cocaine.
    Moody CA; Frambes NA; Spear LP
    Psychopharmacology (Berl); 1992; 108(3):256-62. PubMed ID: 1355920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-dependent modulation of LY 171555-induced defensive behavior in the mouse.
    Cabib S; Puglisi-Allegra S
    Psychopharmacology (Berl); 1989; 97(2):166-8. PubMed ID: 2498923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of dopamine D2 agonist quinpirole upon the dorsal immobility response in rats.
    Meyer ME; Meyer ME; Potter TJ; Van Hartesveldt C
    Pharmacol Biochem Behav; 1992 Jun; 42(2):257-9. PubMed ID: 1352900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buspirone increases social investigation in pair-housed male mice; comparison with the effects of chlordiazepoxide.
    Gao B; Cutler MG
    Neuropharmacology; 1993 May; 32(5):429-37. PubMed ID: 8321425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogenetic quinpirole treatment induces vertical jumping activity in rats.
    Kostrzewa RM; Guo J; Kostrzewa FP
    Eur J Pharmacol; 1993 Aug; 239(1-3):183-7. PubMed ID: 7901028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
    Svensson K; Ekman A; Piercey MF; Hoffmann WE; Lum JT; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):263-74. PubMed ID: 1683686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole.
    Eilam D; Szechtman H
    Pharmacol Biochem Behav; 1990 Aug; 36(4):989-91. PubMed ID: 1977180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.
    Rosenzweig-Lipson S; Barrett JE
    Pharmacol Biochem Behav; 1995 Aug; 51(4):843-8. PubMed ID: 7675867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole.
    Sullivan R; Dogaru C; Szechtman H
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1217-9. PubMed ID: 1361993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic effect of D-2 agonist quinpirole on locomotion and movements.
    Eilam D; Szechtman H
    Eur J Pharmacol; 1989 Feb; 161(2-3):151-7. PubMed ID: 2566488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test.
    Nikulina EM; Skrinskaya JA; Popova NK
    Psychopharmacology (Berl); 1991; 105(4):525-9. PubMed ID: 1685251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intra-accumbens administration of dopamine agonists on stress-induced behavioural deficit.
    Płaźnik A; Stefański R; Puciłowski O; Kostowski W
    J Pharm Pharmacol; 1990 Feb; 42(2):79-84. PubMed ID: 1972406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.